Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer
Clinical trial NCT03464942 · COMPLETED
Trial details
- NCT number
- NCT03464942
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2023-06-22
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.